Illuminating Therapeutic Prospects: Unraveling the EVI1-CTBP2 Axis in Acute Myeloid Leukemia (AML)

by Manisha Kashyap, PhD

In a seminal study recently published in Science Advances, researchers have unearthed a compelling therapeutic avenue in the complex landscape of acute myeloid leukemia (AML). The article, titled "Oncogene EVI1 Drives Acute Myeloid Leukemia Via a Targetable Interaction with CTBP2," not only sheds light on the molecular intricacies driving AML but also underscores a transformative opportunity for tailored therapeutic interventions.

Login Or Register To Read Full Story